Biopharma firm EnteroBiotix has raised more than £27m in funding from new and existing investors to expand its work. The company focuses on gut health and employs some 50 people developing microbiome medicines. It is carrying out clinical trials of drugs designed to prevent and treat a range of conditions …
Read More »Gut health firm EnteroBiotix secures £27m funding
